StonvexLoading…
StonvexStonvexStonvexCore line items from DERM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $61.24M | $55.13M | $59.66M | $71.00M |
Operating Income | $-8.17M | $-13.68M | $-2.07M | $-27.52M |
Net Income | $-11.43M | $-14.67M | $-3.85M | $-29.63M |
EPS (Diluted) | $-0.47 | $-0.72 | $-0.21 | $-1.69 |
Total Assets | $94.59M | $80.24M | $76.85M | $105.16M |
Total Liabilities | $62.74M | $60.17M | $56.50M | $88.18M |
Cash & Equivalents | $24.09M | $20.30M | $27.44M | $32.00M |
Free Cash Flow OCF − CapEx | Not available | $-24.13M | $240.00K | $-33.53M |
Shares Outstanding | 24.50M | 20.43M | 18.23M | 17.53M |